APA

Mele A., Sparaventi G., Guiducci B., Nicolini G., d'Adamo F., Leopardi G., Delfini C., Piccaluga P. & Visani G. (20060303). Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report. : Haematologica.

Chicago

Mele Anna, Sparaventi Giovanni, Guiducci Barbara, Nicolini Giuseppina, d'Adamo Francesca, Leopardi Giuliana, Delfini Costante, Piccaluga Pierpaolo and Visani Giuseppe. 20060303. Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report. : Haematologica.

Harvard

Mele A., Sparaventi G., Guiducci B., Nicolini G., d'Adamo F., Leopardi G., Delfini C., Piccaluga P. and Visani G. (20060303). Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report. : Haematologica.

MLA

Mele Anna, Sparaventi Giovanni, Guiducci Barbara, Nicolini Giuseppina, d'Adamo Francesca, Leopardi Giuliana, Delfini Costante, Piccaluga Pierpaolo and Visani Giuseppe. Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report. : Haematologica. 20060303.